Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Filter results by:

Showing: Prevention & Screening / Bioinformatics

Research: Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy

Abstract | Full Article | PDF Published: 06 Jun 2019 / https://doi.org/10.3332/ecancer.2019.934

Conference Report: Highlights from the 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), 17–18 January 2019, Egypt

Abstract | Full Article | PDF Published: 01 May 2019 / https://doi.org/10.3332/ecancer.2019.926

Research: The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly(ADP-ribose) by self-assembly and not depletion of topoisomerase 2B

Abstract | Full Article | PDF Published: 21 Dec 2018 / https://doi.org/10.3332/ecancer.2018.889

Special Issue: The implementation of omics technologies in cancer microbiome research

Abstract | Full Article | PDF Published: 05 Sep 2018 / https://doi.org/10.3332/ecancer.2018.864

Review: Adipose tissue stem cells in regenerative medicine

Abstract | Full Article | PDF | Español Published: 28 Mar 2018 / https://doi.org/10.3332/ecancer.2018.822

Conference Report: Highlights from the Inaugural International Cancer Microbiome Consortium Meeting (ICMC), 5–6 September 2017, London, UK

Abstract | Full Article | PDF Published: 20 Dec 2017 / https://doi.org/10.3332/ecancer.2017.791

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Abstract | Full Article | PDF Published: 16 Dec 2016 / https://doi.org/10.3332/ecancer.2016.703

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Abstract | Full Article | PDF Published: 09 Nov 2016 / https://doi.org/10.3332/ecancer.2016.691

Research: Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer

Abstract | Full Article | PDF Published: 01 Sep 2016 / https://doi.org/10.3332/ecancer.2016.671

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

Abstract | Full Article | PDF Published: 01 Aug 2016 / https://doi.org/10.3332/ecancer.2016.660



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation